{"id":"https://openalex.org/W2093484445","doi":"https://doi.org/10.1016/s0149-2918(02)80048-0","title":"Changing patterns of initial drug therapy for the treatment of hypertension in a medicaid population, 1997\u20132000","display_name":"Changing patterns of initial drug therapy for the treatment of hypertension in a medicaid population, 1997\u20132000","publication_year":2002,"publication_date":"2002-09-01","ids":{"openalex":"https://openalex.org/W2093484445","doi":"https://doi.org/10.1016/s0149-2918(02)80048-0","mag":"2093484445","pmid":"https://pubmed.ncbi.nlm.nih.gov/12380636"},"language":"en","primary_location":{"id":"doi:10.1016/s0149-2918(02)80048-0","doi":"https://doi.org/10.1016/s0149-2918(02)80048-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0149-2918(02)80048-0","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Robert Weiss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Robert Weiss","raw_affiliation_strings":["Androscoggin Cardiology Associates, Auburn, Maine 04210, USA. rweiss@exploremaine.com","Androscoggin Cardiology Associates, Auburn, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Androscoggin Cardiology Associates, Auburn, Maine 04210, USA. rweiss@exploremaine.com","institution_ids":[]},{"raw_affiliation_string":"Androscoggin Cardiology Associates, Auburn, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070948956","display_name":"Kevin S. Buckley","orcid":"https://orcid.org/0000-0003-1686-6266","observed_orcids":["https://orcid.org/0000-0003-1686-6266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Buckley","raw_affiliation_strings":["Goold Health Systems, Augusta, Maine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Goold Health Systems, Augusta, Maine, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110807166","display_name":"Timothy M. Clifford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy Clifford","raw_affiliation_strings":["Goold Health Systems, Augusta, Maine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Goold Health Systems, Augusta, Maine, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4240,"currency":"USD","value_usd":4240},"apc_paid":null,"fwci":1.0526,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.80404429,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"24","issue":"9","first_page":"1451","last_page":"1462"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12664","display_name":"Clinical practice guidelines implementation","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12075","display_name":"Sodium Intake and Health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8920000195503235},{"id":"https://openalex.org/keywords/initial-antihypertensive-therapy","display_name":"initial antihypertensive therapy","score":0.8489999771118164},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.628000020980835},{"id":"https://openalex.org/keywords/thiazide-diuretics","display_name":"thiazide diuretics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9509999752044678},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/jnc-guidelines","display_name":"JNC guidelines","score":0.6389999985694885},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.8700000047683716},{"id":"https://openalex.org/keywords/newly-diagnosed-hypertension","display_name":"newly diagnosed hypertension","score":0.8859999775886536},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.9120000004768372},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8389999866485596},{"id":"https://openalex.org/keywords/medicaid","display_name":"Medicaid","score":0.49399998784065247},{"id":"https://openalex.org/keywords/maine","display_name":"Maine","score":0.7039999961853027},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.675000011920929},{"id":"https://openalex.org/keywords/drug-use-trends","display_name":"drug use trends","score":0.45899999141693115},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.4690000116825104},{"id":"https://openalex.org/keywords/age-differences","display_name":"age differences","score":0.9509999752044678},{"id":"https://openalex.org/keywords/racial-differences","display_name":"racial differences","score":0.3869999945163727},{"id":"https://openalex.org/keywords/medicare-part-d","display_name":"Medicare Part D","score":0.46399998664855957},{"id":"https://openalex.org/keywords/medicare-advantage","display_name":"Medicare Advantage","score":0.4779999852180481},{"id":"https://openalex.org/keywords/medicare-part-a","display_name":"Medicare Part A","score":0.367000013589859}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9672930836677551},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.8409918546676636},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5607905983924866},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4690224230289459},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33945757150650024},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.19347229599952698},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.12385964393615723},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.05275574326515198},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001581","descriptor_name":"Benzothiadiazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008281","descriptor_name":"Maine","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008484","descriptor_name":"Medicaid","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019983","descriptor_name":"Guideline Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D049993","descriptor_name":"Sodium Chloride Symporter Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0149-2918(02)80048-0","doi":"https://doi.org/10.1016/s0149-2918(02)80048-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0149-2918(02)80048-0","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},{"id":"pmid:12380636","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12380636","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Journal Article"},{"id":"mag:3145102349","doi":null,"is_oa":false,"landing_page_url":"https://bdsp-ehesp.inist.fr/vibad/index.php?action=getRecordDetail&idt=274822","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical Therapeutics","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1808940735","https://openalex.org/W1968125938","https://openalex.org/W1972561907","https://openalex.org/W2026070904","https://openalex.org/W2034294525","https://openalex.org/W2041281883","https://openalex.org/W2072141026","https://openalex.org/W2109861453","https://openalex.org/W2118194784","https://openalex.org/W2166089332","https://openalex.org/W2168095920","https://openalex.org/W2249808841","https://openalex.org/W2297753288","https://openalex.org/W2414167269","https://openalex.org/W4242459468"],"related_works":["https://openalex.org/W2048316125","https://openalex.org/W2291918900","https://openalex.org/W2068100590","https://openalex.org/W2113532407","https://openalex.org/W2035836457","https://openalex.org/W2131489153","https://openalex.org/W2093492051","https://openalex.org/W7096052819","https://openalex.org/W1910766202","https://openalex.org/W2040601284"],"abstract_inverted_index":null,"counts_by_year":[{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}